Evaluation of affinity matured Affibody molecules for imaging of the immune checkpoint protein B7-H3
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluation of affinity matured Affibody molecules for imaging of the immune checkpoint protein B7-H3
Authors
Keywords
-
Journal
NUCLEAR MEDICINE AND BIOLOGY
Volume 124-125, Issue -, Pages 108384
Publisher
Elsevier BV
Online
2023-09-01
DOI
10.1016/j.nucmedbio.2023.108384
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Role of Molecular Imaging in Personalized Medicine
- (2023) Suliman Salih et al. Journal of Personalized Medicine
- Human Epidermal Growth Factor Receptor 2–Targeting [68Ga]Ga-ABY-025 PET/CT Predicts Early Metabolic Response in Metastatic Breast Cancer
- (2023) Ali Alhuseinalkhudhur et al. JOURNAL OF NUCLEAR MEDICINE
- Experimental Therapy of HER2-Expressing Xenografts Using the Second-Generation HER2-Targeting Affibody Molecule 188Re-ZHER2:41071
- (2022) Yongsheng Liu et al. Pharmaceutics
- Preclinical Evaluation of a New Format of 68Ga- and 111In-Labeled Affibody Molecule ZIGF-1R:4551 for the Visualization of IGF-1R Expression in Malignant Tumors Using PET and SPECT
- (2022) Yongsheng Liu et al. Pharmaceutics
- Evaluation of an Affibody-Based Binder for Imaging of Immune Check-Point Molecule B7-H3
- (2022) Maryam Oroujeni et al. Pharmaceutics
- Phase 1 study of intraventricular 131I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies
- (2022) Kim Kramer et al. Journal of Hematology & Oncology
- Hopes on immunotherapy targeting B7-H3 in neuroblastoma
- (2022) Rafael Pulido et al. Translational Oncology
- Preclinical Evaluation of 99mTc-ZHER2:41071, a Second-Generation Affibody-Based HER2-Visualizing Imaging Probe with a Low Renal Uptake
- (2021) Maryam Oroujeni et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Silencing of CD276 suppresses lung cancer progression by regulating integrin signaling
- (2020) Fang Li et al. Journal of Thoracic Disease
- B7H3-Directed Intraperitoneal Radioimmunotherapy With Radioiodinated Omburtamab for Desmoplastic Small Round Cell Tumor and Other Peritoneal Tumors: Results of a Phase I Study
- (2020) Shakeel Modak et al. JOURNAL OF CLINICAL ONCOLOGY
- Influence of composition of cysteine-containing peptide-based chelators on biodistribution of 99mTc-labeled anti-EGFR affibody molecules
- (2018) Maryam Oroujeni et al. AMINO ACIDS
- Same-Day Imaging Using Small Proteins: Clinical Experience and Translational Prospects in Oncology
- (2018) Ahmet Krasniqi et al. JOURNAL OF NUCLEAR MEDICINE
- 212 Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models
- (2018) Benjamin B. Kasten et al. NUCLEAR MEDICINE AND BIOLOGY
- Tumor B7-H3 (CD276) Expression and Survival in Pancreatic Cancer
- (2018) Kentaro Inamura et al. Journal of Clinical Medicine
- Molecular imaging of T cell co-regulator factor B7-H3 with 89Zr-DS-5573a
- (2018) Ingrid Julienne Georgette Burvenich et al. Theranostics
- Affibody Molecules in Biotechnological and Medical Applications
- (2017) Stefan Ståhl et al. TRENDS IN BIOTECHNOLOGY
- Feasibility of imaging of epidermal growth factor receptor expression with ZEGFR:2377 affibody molecule labeled with 99mTc using a peptide-based cysteine-containing chelator
- (2016) Ken G. Andersson et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Comparative Evaluation of Affibody Molecules for Radionuclide Imaging of in Vivo Expression of Carbonic Anhydrase IX
- (2016) Javad Garousi et al. MOLECULAR PHARMACEUTICS
- Quantitative assessment of Zirconium-89 labeled cetuximab using PET/CT imaging in patients with advanced head and neck cancer: a theragnostic approach
- (2016) Aniek J.G. Even et al. Oncotarget
- Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [68Ga]ABY-025 Affibody PET/CT
- (2016) Jens Sörensen et al. Theranostics
- In vivo imaging with antibodies and engineered fragments
- (2015) Amanda C. Freise et al. MOLECULAR IMMUNOLOGY
- Comparative evaluation of 111In-labeled NOTA-conjugated affibody molecules for visualization of HER3 expression in malignant tumors
- (2015) KEN G ANDERSSON et al. ONCOLOGY REPORTS
- Advances in SPECT and PET Hardware
- (2015) Piotr J. Slomka et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Affibody-mediated PET imaging of HER3 expression in malignant tumours
- (2015) Maria Rosestedt et al. Scientific Reports
- Evaluation of 99mTc-ZIGF1R:4551-GGGC affibody molecule, a new probe for imaging of insulin-like growth factor type 1 receptor expression
- (2014) Bogdan Mitran et al. AMINO ACIDS
- Selection of an optimal cysteine-containing peptide-based chelator for labeling of affibody molecules with 188Re
- (2014) Mohamed Altai et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- First-in-Human Molecular Imaging of HER2 Expression in Breast Cancer Metastases Using the 111In-ABY-025 Affibody Molecule
- (2014) J. Sorensen et al. JOURNAL OF NUCLEAR MEDICINE
- Gallium-68-Labeled Affibody Molecule for PET Imaging of PDGFRβ Expression in Vivo
- (2014) Joanna Strand et al. MOLECULAR PHARMACEUTICS
- B7-H3 Associated with Tumor Progression and Epigenetic Regulatory Activity in Cutaneous Melanoma
- (2013) Jinhua Wang et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- HAHAHA, HEHEHE, HIHIHI, or HKHKHK: Influence of Position and Composition of Histidine Containing Tags on Biodistribution of [99mTc(CO)3]+-Labeled Affibody Molecules
- (2013) Camilla Hofström et al. JOURNAL OF MEDICINAL CHEMISTRY
- Engineered antibodies for molecular imaging of cancer
- (2013) Anna M. Wu METHODS
- Correction: Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification
- (2013) Magdalena Malm et al. PLoS One
- Deciphering complex protein interaction kinetics using Interaction Map
- (2012) Danièle Altschuh et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- B7-H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressiveness and postoperative recurrence
- (2012) Tai-Wei Sun et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- B7-H3 expression in colorectal cancer: Nuclear localization strongly predicts poor outcome in colon cancer
- (2012) Vibeke Anett Ingebrigtsen et al. INTERNATIONAL JOURNAL OF CANCER
- Tumor Targeting Using Affibody Molecules: Interplay of Affinity, Target Expression Level, and Binding Site Composition
- (2012) V. Tolmachev et al. JOURNAL OF NUCLEAR MEDICINE
- Order of amino acids in C-terminal cysteine-containing peptide-based chelators influences cellular processing and biodistribution of 99mTc-labeled recombinant Affibody molecules
- (2011) Mohamed Altai et al. AMINO ACIDS
- Costimulatory Protein 4IgB7H3 Drives the Malignant Phenotype of Glioblastoma by Mediating Immune Escape and Invasiveness
- (2011) D. Lemke et al. CLINICAL CANCER RESEARCH
- Engineered High-Affinity Affibody Molecules Targeting Platelet-Derived Growth Factor Receptor β In Vivo
- (2011) M. Lindborg et al. JOURNAL OF MOLECULAR BIOLOGY
- Molecular Design and Optimization of 99mTc-Labeled Recombinant Affibody Molecules Improves Their Biodistribution and Imaging Properties
- (2011) H. Wallberg et al. JOURNAL OF NUCLEAR MEDICINE
- B7-H3 Over Expression in Prostate Cancer Promotes Tumor Cell Progression
- (2011) Hexing Yuan et al. JOURNAL OF UROLOGY
- HEHEHE-Tagged Affibody Molecule May Be Purified by IMAC, Is Conveniently Labeled with [99mTc(CO)3]+, and Shows Improved Biodistribution with Reduced Hepatic Radioactivity Accumulation
- (2010) Vladimir Tolmachev et al. BIOCONJUGATE CHEMISTRY
- Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas
- (2010) Xingxing Zang et al. MODERN PATHOLOGY
- Kit formulation for 99mTc-labeling of recombinant anti-HER2 Affibody molecules with a C-terminally engineered cysteine
- (2010) Sara Ahlgren et al. NUCLEAR MEDICINE AND BIOLOGY
- Clinical importance of B7-H3 expression in human pancreatic cancer
- (2009) I Yamato et al. BRITISH JOURNAL OF CANCER
- Design, synthesis and biological evaluation of a multifunctional HER2-specific Affibody molecule for molecular imaging
- (2009) Thuy A. Tran et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Affibody Molecules for Epidermal Growth Factor Receptor Targeting In Vivo: Aspects of Dimerization and Labeling Chemistry
- (2009) V. Tolmachev et al. JOURNAL OF NUCLEAR MEDICINE
- Targeting of HER2-Expressing Tumors with a Site-Specifically 99mTc-Labeled Recombinant Affibody Molecule, ZHER2:2395, with C-Terminally Engineered Cysteine
- (2009) S. Ahlgren et al. JOURNAL OF NUCLEAR MEDICINE
- PET versus SPECT: strengths, limitations and challenges
- (2009) Arman Rahmim et al. NUCLEAR MEDICINE COMMUNICATIONS
- The Immunoregulatory Protein Human B7H3 is a Tumor-Associated Antigen that Regulates Tumor Cell Migration and Invasion
- (2008) Yih-Wen Chen et al. CURRENT CANCER DRUG TARGETS
- Directed Evolution to Low Nanomolar Affinity of a Tumor-Targeting Epidermal Growth Factor Receptor-Binding Affibody Molecule
- (2008) Mikaela Friedman et al. JOURNAL OF MOLECULAR BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started